Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (41-50 of 747) with videos related to

Pageof 75
Sort By:
Hepatology (Baltimore, Md.)|January 19, 2020
PNPLA3 Genotype and Risk of Liver and All-Cause MortalityStefan Stender, Rohit Loomba
Hepatology (Baltimore, Md.)|February 5, 2021
Emerging Metabolic and Transcriptomic Signature of PNPLA3-Associated NASHDebanjan Dhar, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2019
PROs of Patient-reported Outcomes for Nonalcoholic Fatty Liver Disease and Effects on Treatment for Nonalcoholic SteatohepatitisMaya Balakrishnan, Rohit Loomba
Alimentary Pharmacology & Therapeutics|June 1, 2019
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implicationsSaumya Jayakumar, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 20, 2019
ReplyCyrielle Caussy, Rohit Loomba
Molecular Metabolism|January 18, 2021
Imaging biomarkers of NAFLD, NASH, and fibrosisVeeral Ajmera, Rohit Loomba
Alimentary Pharmacology & Therapeutics|June 10, 2026
Letter: Beyond Feasibility-The Need for Longer Duration and Composite NIT Endpoints in Biopsy-Free MASH Trials: Authors' ReplyVeeral Ajmera, Rohit Loomba
Journal of Hepatology|February 3, 2023
Reply to: "Screening for NAFLD and its severity in type 2 diabetic patients: Value of magnetic resonance imaging and outstanding issues"Veeral Ajmera, Rohit Loomba
Hepatology (Baltimore, Md.)|April 4, 2023
Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCCSuzanne R Sharpton, Rohit Loomba
Journal of Hepatology|April 13, 2015
Exercise and improvement of NAFLD: Practical recommendationsRohit Loomba, Helena Cortez-Pinto
Pageof 75

Showing results (41-50 of 747) with videos related to

Sort By:
Pageof 75
Hepatology (Baltimore, Md.)|January 19, 2020
PNPLA3 Genotype and Risk of Liver and All-Cause MortalityStefan Stender, Rohit Loomba
Hepatology (Baltimore, Md.)|February 5, 2021
Emerging Metabolic and Transcriptomic Signature of PNPLA3-Associated NASHDebanjan Dhar, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 14, 2019
PROs of Patient-reported Outcomes for Nonalcoholic Fatty Liver Disease and Effects on Treatment for Nonalcoholic SteatohepatitisMaya Balakrishnan, Rohit Loomba
Alimentary Pharmacology & Therapeutics|June 1, 2019
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implicationsSaumya Jayakumar, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 20, 2019
ReplyCyrielle Caussy, Rohit Loomba
Molecular Metabolism|January 18, 2021
Imaging biomarkers of NAFLD, NASH, and fibrosisVeeral Ajmera, Rohit Loomba
Alimentary Pharmacology & Therapeutics|June 10, 2026
Letter: Beyond Feasibility-The Need for Longer Duration and Composite NIT Endpoints in Biopsy-Free MASH Trials: Authors' ReplyVeeral Ajmera, Rohit Loomba
Journal of Hepatology|February 3, 2023
Reply to: "Screening for NAFLD and its severity in type 2 diabetic patients: Value of magnetic resonance imaging and outstanding issues"Veeral Ajmera, Rohit Loomba
Hepatology (Baltimore, Md.)|April 4, 2023
Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCCSuzanne R Sharpton, Rohit Loomba
Journal of Hepatology|April 13, 2015
Exercise and improvement of NAFLD: Practical recommendationsRohit Loomba, Helena Cortez-Pinto
Pageof 75